<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head>

<meta charset="utf-8">
<meta name="generator" content="quarto-1.1.189">

<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">


<title>BS4019: Discovery and Development of Therapeutic Antibodies - 2&nbsp; Therapeutic Antibody Design</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
div.columns{display: flex; gap: min(4vw, 1.5em);}
div.column{flex: auto; overflow-x: auto;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
ul.task-list li input[type="checkbox"] {
  width: 0.8em;
  margin: 0 0.8em 0.2em -1.6em;
  vertical-align: middle;
}
</style>


<script src="site_libs/quarto-nav/quarto-nav.js"></script>
<script src="site_libs/quarto-nav/headroom.min.js"></script>
<script src="site_libs/clipboard/clipboard.min.js"></script>
<script src="site_libs/quarto-search/autocomplete.umd.js"></script>
<script src="site_libs/quarto-search/fuse.min.js"></script>
<script src="site_libs/quarto-search/quarto-search.js"></script>
<meta name="quarto:offset" content="./">
<link href="./wk3.html" rel="next">
<link href="./intro.html" rel="prev">
<script src="site_libs/quarto-html/quarto.js"></script>
<script src="site_libs/quarto-html/popper.min.js"></script>
<script src="site_libs/quarto-html/tippy.umd.min.js"></script>
<script src="site_libs/quarto-html/anchor.min.js"></script>
<link href="site_libs/quarto-html/tippy.css" rel="stylesheet">
<link href="site_libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" class="quarto-color-scheme" id="quarto-text-highlighting-styles">
<link href="site_libs/quarto-html/quarto-syntax-highlighting-dark.css" rel="prefetch" class="quarto-color-scheme quarto-color-alternate" id="quarto-text-highlighting-styles">
<script src="site_libs/bootstrap/bootstrap.min.js"></script>
<link href="site_libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="site_libs/bootstrap/bootstrap.min.css" rel="stylesheet" class="quarto-color-scheme" id="quarto-bootstrap" data-mode="light">
<link href="site_libs/bootstrap/bootstrap-dark.min.css" rel="prefetch" class="quarto-color-scheme quarto-color-alternate" id="quarto-bootstrap" data-mode="dark">
<script id="quarto-search-options" type="application/json">{
  "location": "sidebar",
  "copy-button": false,
  "collapse-after": 3,
  "panel-placement": "start",
  "type": "textbox",
  "limit": 20,
  "language": {
    "search-no-results-text": "No results",
    "search-matching-documents-text": "matching documents",
    "search-copy-link-title": "Copy link to search",
    "search-hide-matches-text": "Hide additional matches",
    "search-more-match-text": "more match in this document",
    "search-more-matches-text": "more matches in this document",
    "search-clear-button-title": "Clear",
    "search-detached-cancel-button-title": "Cancel",
    "search-submit-button-title": "Submit"
  }
}</script>
<script async="" src="https://hypothes.is/embed.js"></script>

  <script src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-chtml-full.js" type="text/javascript"></script>

</head>

<body class="nav-sidebar floating">

<div id="quarto-search-results"></div>
  <header id="quarto-header" class="headroom fixed-top">
  <nav class="quarto-secondary-nav" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar" aria-controls="quarto-sidebar" aria-expanded="false" aria-label="Toggle sidebar navigation" onclick="if (window.quartoToggleHeadroom) { window.quartoToggleHeadroom(); }">
    <div class="container-fluid d-flex justify-content-between">
      <h1 class="quarto-secondary-nav-title"><span class="chapter-number">2</span>&nbsp; <span class="chapter-title">Therapeutic Antibody Design</span></h1>
      <button type="button" class="quarto-btn-toggle btn" aria-label="Show secondary navigation">
        <i class="bi bi-chevron-right"></i>
      </button>
    </div>
  </nav>
</header>
<!-- content -->
<div id="quarto-content" class="quarto-container page-columns page-rows-contents page-layout-article">
<!-- sidebar -->
  <nav id="quarto-sidebar" class="sidebar collapse sidebar-navigation floating overflow-auto">
    <div class="pt-lg-2 mt-2 text-left sidebar-header">
    <div class="sidebar-title mb-0 py-0">
      <a href="./">BS4019: Discovery and Development of Therapeutic Antibodies</a> 
        <div class="sidebar-tools-main tools-wide">
    <a href="https://github.com/kevfo/BS4019-stuff" title="Source Code" class="sidebar-tool px-1"><i class="bi bi-github"></i></a>
    <a href="" title="Share" id="sidebar-tool-dropdown-0" class="sidebar-tool dropdown-toggle px-1" data-bs-toggle="dropdown" aria-expanded="false"><i class="bi bi-share"></i></a>
    <ul class="dropdown-menu" aria-labelledby="sidebar-tool-dropdown-0">
        <li>
          <a class="dropdown-item sidebar-tools-main-item" href="https://twitter.com/intent/tweet?url=|url|">
            <i class="bi bi-bi-twitter pe-1"></i>
          Twitter
          </a>
        </li>
        <li>
          <a class="dropdown-item sidebar-tools-main-item" href="https://www.facebook.com/sharer/sharer.php?u=|url|">
            <i class="bi bi-bi-facebook pe-1"></i>
          Facebook
          </a>
        </li>
    </ul>
  <a href="" class="quarto-color-scheme-toggle sidebar-tool" onclick="window.quartoToggleColorScheme(); return false;" title="Toggle dark mode"><i class="bi"></i></a>
  <a href="" class="quarto-reader-toggle sidebar-tool" onclick="window.quartoToggleReader(); return false;" title="Toggle reader mode">
  <div class="quarto-reader-toggle-btn">
  <i class="bi"></i>
  </div>
</a>
</div>
    </div>
      </div>
      <div class="mt-2 flex-shrink-0 align-items-center">
        <div class="sidebar-search">
        <div id="quarto-search" class="" title="Search"></div>
        </div>
      </div>
    <div class="sidebar-menu-container"> 
    <ul class="list-unstyled mt-1">
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./index.html" class="sidebar-item-text sidebar-link">Preface</a>
  </div>
</li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a class="sidebar-item-text sidebar-link text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-1" aria-expanded="true"><strong>PART 1 : LECTURES</strong></a>
          <a class="sidebar-item-toggle text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-1" aria-expanded="true">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-1" class="collapse list-unstyled sidebar-section depth1 show">  
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./intro.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">1</span>&nbsp; <span class="chapter-title">Introduction to Antibodies</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./wk2.html" class="sidebar-item-text sidebar-link active"><span class="chapter-number">2</span>&nbsp; <span class="chapter-title">Therapeutic Antibody Design</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./wk3.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">3</span>&nbsp; <span class="chapter-title">Pre-clinical Validation of Antibodies</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./wk5.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">4</span>&nbsp; <span class="chapter-title">Case Study: Rituximab</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./wk6.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">5</span>&nbsp; <span class="chapter-title">Clinical Development of Antibodies</span></a>
  </div>
</li>
      </ul>
  </li>
    </ul>
    </div>
</nav>
<!-- margin-sidebar -->
    <div id="quarto-margin-sidebar" class="sidebar margin-sidebar">
        <nav id="TOC" role="doc-toc" class="toc-active">
    <h2 id="toc-title">Table of contents</h2>
   
  <ul>
  <li><a href="#begin2" id="toc-begin2" class="nav-link active" data-scroll-target="#begin2"><span class="toc-section-number">2.1</span>  Surfaces of the Crystallizable Fragment (i.e., Fc)</a>
  <ul class="collapse">
  <li><a href="#complement-system-recruitment" id="toc-complement-system-recruitment" class="nav-link" data-scroll-target="#complement-system-recruitment"><span class="toc-section-number">2.1.1</span>  Complement System Recruitment</a></li>
  <li><a href="#recruiting-nk-cells-and-macrophages" id="toc-recruiting-nk-cells-and-macrophages" class="nav-link" data-scroll-target="#recruiting-nk-cells-and-macrophages"><span class="toc-section-number">2.1.2</span>  Recruiting NK Cells and Macrophages</a></li>
  <li><a href="#extending-serum-half-lives-via-binding-of-fc-neonatal-receptors-i.e.-fcrn" id="toc-extending-serum-half-lives-via-binding-of-fc-neonatal-receptors-i.e.-fcrn" class="nav-link" data-scroll-target="#extending-serum-half-lives-via-binding-of-fc-neonatal-receptors-i.e.-fcrn"><span class="toc-section-number">2.1.3</span>  Extending Serum Half Lives via Binding of FC Neonatal Receptors (i.e., FcRn)</a></li>
  </ul></li>
  <li><a href="#fc-receptors" id="toc-fc-receptors" class="nav-link" data-scroll-target="#fc-receptors"><span class="toc-section-number">2.2</span>  Fc Receptors</a></li>
  <li><a href="#igg-subclasses" id="toc-igg-subclasses" class="nav-link" data-scroll-target="#igg-subclasses"><span class="toc-section-number">2.3</span>  IgG Subclasses</a></li>
  <li><a href="#steps" id="toc-steps" class="nav-link" data-scroll-target="#steps"><span class="toc-section-number">2.4</span>  Steps to Designing a Therapeutic Antibody</a>
  <ul class="collapse">
  <li><a href="#step-1-understanding-the-disease" id="toc-step-1-understanding-the-disease" class="nav-link" data-scroll-target="#step-1-understanding-the-disease"><span class="toc-section-number">2.4.1</span>  Step #1: Understanding the Disease</a></li>
  <li><a href="#step-2-identifying-the-target-molecule-and-the-mode-of-action" id="toc-step-2-identifying-the-target-molecule-and-the-mode-of-action" class="nav-link" data-scroll-target="#step-2-identifying-the-target-molecule-and-the-mode-of-action"><span class="toc-section-number">2.4.2</span>  Step #2: Identifying the Target Molecule and the Mode of Action</a></li>
  <li><a href="#step-3-generating-the-antigen-binding-fragments" id="toc-step-3-generating-the-antigen-binding-fragments" class="nav-link" data-scroll-target="#step-3-generating-the-antigen-binding-fragments"><span class="toc-section-number">2.4.3</span>  Step #3: Generating the Antigen Binding Fragments</a></li>
  <li><a href="#step-5-humanizing-antibodies" id="toc-step-5-humanizing-antibodies" class="nav-link" data-scroll-target="#step-5-humanizing-antibodies"><span class="toc-section-number">2.4.4</span>  Step #5: Humanizing Antibodies</a></li>
  <li><a href="#step-6-validating-molecules" id="toc-step-6-validating-molecules" class="nav-link" data-scroll-target="#step-6-validating-molecules"><span class="toc-section-number">2.4.5</span>  Step #6: Validating Molecules</a></li>
  </ul></li>
  <li><a href="#phages-and-library-displays" id="toc-phages-and-library-displays" class="nav-link" data-scroll-target="#phages-and-library-displays"><span class="toc-section-number">2.5</span>  Phages and Library Displays</a>
  <ul class="collapse">
  <li><a href="#life-cycle-of-a-phage" id="toc-life-cycle-of-a-phage" class="nav-link" data-scroll-target="#life-cycle-of-a-phage"><span class="toc-section-number">2.5.1</span>  Life Cycle of a Phage</a></li>
  <li><a href="#phage-display-formats" id="toc-phage-display-formats" class="nav-link" data-scroll-target="#phage-display-formats"><span class="toc-section-number">2.5.2</span>  Phage Display Formats</a></li>
  <li><a href="#library-creation-from-cdna" id="toc-library-creation-from-cdna" class="nav-link" data-scroll-target="#library-creation-from-cdna"><span class="toc-section-number">2.5.3</span>  Library Creation from cDNA</a></li>
  <li><a href="#kunkel-mutagenesis" id="toc-kunkel-mutagenesis" class="nav-link" data-scroll-target="#kunkel-mutagenesis"><span class="toc-section-number">2.5.4</span>  Kunkel Mutagenesis</a></li>
  </ul></li>
  </ul>
<div class="toc-actions"><div><i class="bi bi-github"></i></div><div class="action-links"><p><a href="https://github.com/kevfo/BS4019-stuff/edit/main/wk2.qmd" class="toc-action">Edit this page</a></p><p><a href="https://github.com/kevfo/BS4019-stuff/issues/new" class="toc-action">Report an issue</a></p></div></div></nav>
    </div>
<!-- main -->
<main class="content" id="quarto-document-content">

<header id="title-block-header" class="quarto-title-block default">
<div class="quarto-title">
<h1 class="title d-none d-lg-block"><span class="chapter-number">2</span>&nbsp; <span class="chapter-title">Therapeutic Antibody Design</span></h1>
</div>



<div class="quarto-title-meta">

    
    
  </div>
  

</header>

<p>This week’s (i.e., week 2) lecture focuses on the following topics:</p>
<ol type="1">
<li>Antibody effector functions</li>
<li>IgG subclasses and their effector functions</li>
<li>Approaches to making therapeutic antibodies</li>
<li>Understanding disease biology</li>
<li>Therapeutic antibody design</li>
</ol>
<section id="begin2" class="level2" data-number="2.1">
<h2 data-number="2.1" class="anchored" data-anchor-id="begin2"><span class="header-section-number">2.1</span> Surfaces of the Crystallizable Fragment (i.e., Fc)</h2>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="images/wk2/fc.jpg" class="img-fluid figure-img" width="438"></p>
<p></p><figcaption class="figure-caption">Surfaces of the Fc</figcaption><p></p>
</figure>
</div>
</div>
</div>
<p>Different surfaces of the Fc each perform a different function:</p>
<ol type="1">
<li><p><strong>Fc<span class="math inline">\(\gamma\)</span>R Binding</strong></p>
<p>Here, glycosylation is important for binding. This is also the site of ADCC<a href="#fn1" class="footnote-ref" id="fnref1" role="doc-noteref"><sup>1</sup></a> and ADCP<a href="#fn2" class="footnote-ref" id="fnref2" role="doc-noteref"><sup>2</sup></a>.</p></li>
<li><p><strong>C1q Binding</strong></p>
<p>This performs CDC.</p></li>
<li><p><strong>FcRn Binding</strong></p>
<p>Protein A/G binding allows for the purification of recombinant antibodies.</p>
<p>This receptor is also responsible for placental transport and serum half-life extension (see below).</p></li>
</ol>
<section id="complement-system-recruitment" class="level3" data-number="2.1.1">
<h3 data-number="2.1.1" class="anchored" data-anchor-id="complement-system-recruitment"><span class="header-section-number">2.1.1</span> Complement System Recruitment</h3>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="images/wk2/cdcr.jpg" class="img-fluid figure-img" width="444"></p>
<p></p><figcaption class="figure-caption">Recruitment Process of the CDC</figcaption><p></p>
</figure>
</div>
</div>
</div>
<p>There are six main steps:</p>
<ol type="1">
<li>A multivalent antibody binds and recruits a C1 complex.</li>
<li>Step 1. ends up initiating a <em>complement activation cascade</em>.</li>
<li>C5 is cleaved into C5a and C5b as a result of 2.</li>
<li>C5a promotes inflammation.</li>
<li>C5b recruits the <strong>M</strong>embrane <strong>A</strong>ttachment <strong>C</strong>omplex (i.e., <strong>MAC</strong>)</li>
<li>The MAC creates pores in the cell membrane - this leads to cell lysis (and eventually, death).</li>
</ol>
</section>
<section id="recruiting-nk-cells-and-macrophages" class="level3" data-number="2.1.2">
<h3 data-number="2.1.2" class="anchored" data-anchor-id="recruiting-nk-cells-and-macrophages"><span class="header-section-number">2.1.2</span> Recruiting NK Cells and Macrophages</h3>
<p>The following process is that of Antibody-Dependent Cellular Cytotoxicity:</p>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="images/wk2/nkcr.jpg" class="img-fluid figure-img" width="510"></p>
<p></p><figcaption class="figure-caption">How NK Cells are Recruited</figcaption><p></p>
</figure>
</div>
</div>
</div>
<p>Once an antibody is bound to the surface of an antigen, an NK cell’s CD16-Fc receptors recognize these antibodies.</p>
<p>As CD-16 are crossed linked, this causes the affected cell to die by apoptosis.</p>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="images/wk2/mcr.jpg" class="img-fluid figure-img" width="498"></p>
<p></p><figcaption class="figure-caption">Recruitment of Macrophages by IgG Antibodies</figcaption><p></p>
</figure>
</div>
</div>
</div>
<p>Once IgG antibodies have bound to an antigen, the IgG antibodies bind to the phagocyte via Fc receptors (Fc<span class="math inline">\(\gamma\)</span>RI).</p>
<p>These signals (i.e., Fc receptor signals) then causes phagocytosis, thereby killing the antigen.</p>
</section>
<section id="extending-serum-half-lives-via-binding-of-fc-neonatal-receptors-i.e.-fcrn" class="level3" data-number="2.1.3">
<h3 data-number="2.1.3" class="anchored" data-anchor-id="extending-serum-half-lives-via-binding-of-fc-neonatal-receptors-i.e.-fcrn"><span class="header-section-number">2.1.3</span> Extending Serum Half Lives via Binding of FC Neonatal Receptors (i.e., FcRn)</h3>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="images/wk2/fcrn.jpg" class="img-fluid figure-img" width="286"></p>
<p></p><figcaption class="figure-caption">How FcRn Binding Works</figcaption><p></p>
</figure>
</div>
</div>
</div>
<p>There are four main processes:</p>
<ol type="1">
<li><p>Endothelial cells engulf fluids containing IgGs and other plasma proteins from their surrounding environments<a href="#fn3" class="footnote-ref" id="fnref3" role="doc-noteref"><sup>3</sup></a>.</p></li>
<li><p>The early endosomes contain FcRns that bind to the IgG antibodies with a high affinity in spite of the slightly acidic environment (i.e., about pH 6).</p></li>
<li><p>IgG-FcRn complexes are directed to recycling endosomes while other proteins become degraded in the lysosomes.</p></li>
<li><p>When IgGs reach cell surfaces, the FcRn binding affinity is reduced due to the pH (i.e., at about 7.4 at this point) - the IgG antibody is released.</p></li>
</ol>
</section>
</section>
<section id="fc-receptors" class="level2" data-number="2.2">
<h2 data-number="2.2" class="anchored" data-anchor-id="fc-receptors"><span class="header-section-number">2.2</span> Fc Receptors</h2>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="images/wk2/fcr.jpg" class="img-fluid figure-img" width="304"></p>
<p></p><figcaption class="figure-caption">Several Fc Receptors</figcaption><p></p>
</figure>
</div>
</div>
</div>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="images/wk2/fcd.jpg" class="img-fluid figure-img" width="614"></p>
<p></p><figcaption class="figure-caption">More Details on Fc Receptors</figcaption><p></p>
</figure>
</div>
</div>
</div>
<p>There are several possible receptors available for the Fc fragment of an antibody, of which the following are the most important:</p>
<ol type="1">
<li><p><strong>Fc<span class="math inline">\(\gamma\)</span>RI</strong></p>
<p>This is important for phagocytosis and activation.</p></li>
<li><p><strong>Fc<span class="math inline">\(\gamma\)</span>RIIIA</strong></p>
<p>This is for ADCC.</p></li>
<li><p><strong>Fc<span class="math inline">\(\gamma\)</span>RIIB</strong></p>
<p>This receptor inhibits phagocytosis and cytokine release.</p></li>
<li><p><strong>FcRn</strong></p>
<p>These extend the serum half-life of the antibody.</p></li>
</ol>
</section>
<section id="igg-subclasses" class="level2" data-number="2.3">
<h2 data-number="2.3" class="anchored" data-anchor-id="igg-subclasses"><span class="header-section-number">2.3</span> IgG Subclasses</h2>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="images/wk2/iggsub.jpg" class="img-fluid figure-img" width="250"></p>
<p></p><figcaption class="figure-caption">Subclasses of the IgG Antibody</figcaption><p></p>
</figure>
</div>
</div>
</div>
<p>There are four main oligomers:</p>
<ol type="1">
<li><p><strong>IgG1</strong></p>
<p>This is always monomeric bivalent and is the most common subclass for therapeutic antibodies.</p></li>
<li><p><strong>IgG2</strong></p>
<p>This is in equilibrium between its monomeric bivalent and dimeric tetravalent forms.</p>
<p>This form is sometimes used to develop therapeutic antibodies.</p></li>
<li><p><strong>IgG3</strong></p>
<p>This is always monomeric bivalent, but not very commonly used to develop therapeutic antibodies.</p></li>
<li><p><strong>IgG4</strong></p>
<p>This subclass exists in three different states: monomeric bivalent (left), monomeric monovalent (middle), and mixed monovalent bi-specific forms (right).</p>
<p>This is used to develop therapeutic antibodies after Fc engineering to stabilize its monomeric bivalent form.</p></li>
</ol>
</section>
<section id="steps" class="level2" data-number="2.4">
<h2 data-number="2.4" class="anchored" data-anchor-id="steps"><span class="header-section-number">2.4</span> Steps to Designing a Therapeutic Antibody</h2>
<p>There are a total of <em>five</em> steps to designing such an antibody:</p>
<section id="step-1-understanding-the-disease" class="level3" data-number="2.4.1">
<h3 data-number="2.4.1" class="anchored" data-anchor-id="step-1-understanding-the-disease"><span class="header-section-number">2.4.1</span> Step #1: Understanding the Disease</h3>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="images/wk2/cancer.jpg" class="img-fluid figure-img" width="358"></p>
<p></p><figcaption class="figure-caption">An Example Diagram of a Localized Tumor</figcaption><p></p>
</figure>
</div>
</div>
</div>
<p>Antibody therapies are generally based on a solid understanding of the mechanisms that underlie the illness being targeted - in this case, cancer.</p>
<p>The diagram above shows a tumor cell that is surrounded by an excess of ATP molecules (i.e., the pink circles) in vivo. These ATP molecules may promote further release of ATP, cell growth (i.e., uncontrolled mitosis), and also immune and inflammatory cell responses.</p>
</section>
<section id="step-2-identifying-the-target-molecule-and-the-mode-of-action" class="level3" data-number="2.4.2">
<h3 data-number="2.4.2" class="anchored" data-anchor-id="step-2-identifying-the-target-molecule-and-the-mode-of-action"><span class="header-section-number">2.4.2</span> Step #2: Identifying the Target Molecule and the Mode of Action</h3>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="images/wk2/step2.jpg" class="img-fluid figure-img" width="798"></p>
<p></p><figcaption class="figure-caption">Possible Modes of Action of an Antibody</figcaption><p></p>
</figure>
</div>
</div>
</div>
<p>Depending on the intended modes of action and / or the target regions of the target (i.e., the epitope) for the antibody in question, a different subclass of IgG antibodies might need to be used.</p>
<p>Recall that IgG1 antibodies excel in targeting carbohydrates while IgG2 antibodies excel in targeting polysaccharides (e.g., sugar coatings).</p>
</section>
<section id="step-3-generating-the-antigen-binding-fragments" class="level3" data-number="2.4.3">
<h3 data-number="2.4.3" class="anchored" data-anchor-id="step-3-generating-the-antigen-binding-fragments"><span class="header-section-number">2.4.3</span> Step #3: Generating the Antigen Binding Fragments</h3>
<p>BS4019 lists two common methods of performing this step:</p>
<section id="animals" class="level4" data-number="2.4.3.1">
<h4 data-number="2.4.3.1" class="anchored" data-anchor-id="animals"><span class="header-section-number">2.4.3.1</span> Using Animals</h4>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="images/wk2/animal.jpg" class="img-fluid figure-img" width="402"></p>
<p></p><figcaption class="figure-caption">Using Mice as Model Organisms for Antibody Generation</figcaption><p></p>
</figure>
</div>
</div>
</div>
<p>In this procedure, an antigen is first injected into an animal (i.e., step 1). A serum (i.e., step 2) can then be extracted to yield a <strong>polyclonal</strong> antibody solution<a href="#fn4" class="footnote-ref" id="fnref4" role="doc-noteref"><sup>4</sup></a>.</p>
<p>Once antibody-producing B-cells can be extracted from the animal, these same B-cells are also fused with tumor cells to form <strong>hybridoma cells</strong> (i.e., step 4). These cells divide indefinitely and in doing so, produce antibodies.</p>
<p>These antibodies are then screened<a href="#fn5" class="footnote-ref" id="fnref5" role="doc-noteref"><sup>5</sup></a> to filter out the correct antibody for mass production before they are <em>clonally expanded</em> to form monoclonal antibodies.</p>
<section id="an-alternative-to-step-4" class="level5" data-number="2.4.3.1.1">
<h5 data-number="2.4.3.1.1" class="anchored" data-anchor-id="an-alternative-to-step-4"><span class="header-section-number">2.4.3.1.1</span> An Alternative to Step 4</h5>
<p>Bioinformatics may also be used to generate a suitable sequence to be fused with tumor cells’ genomes.</p>
<p>The VH and VL regions of the Fab fragment of the target antibody can then be amplified via in vivo methods (e.g., phage displays).</p>
</section>
</section>
<section id="phage" class="level4" data-number="2.4.3.2">
<h4 data-number="2.4.3.2" class="anchored" data-anchor-id="phage"><span class="header-section-number">2.4.3.2</span> Phage Libraries</h4>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="images/wk2/phage.jpg" class="img-fluid figure-img" width="412"></p>
<p></p><figcaption class="figure-caption">Antibody Production Using Bacteriophages</figcaption><p></p>
</figure>
</div>
</div>
</div>
<p>A library that contains about 10<sup>10</sup> is first displayed at the surface of a bacteriophage before it is exposed to an antigen (which is typically the protein of interest that has been immobilized on a surface). In doing so, non-binding phages are washed away.</p>
<p>The binding phages then go on to infect <em>E. coli</em> cells - this process happens about two to six times. An ELISA assay is typically used after this to ensure binding. The phages may also be sequenced to identify Fab sequence.</p>
<section id="alternative-steps" class="level5" data-number="2.4.3.2.1">
<h5 data-number="2.4.3.2.1" class="anchored" data-anchor-id="alternative-steps"><span class="header-section-number">2.4.3.2.1</span> Alternative Steps</h5>
<p>Instead of developing a phage library, a yeast or mRNA display can be used instead.</p>
<p>Otherwise, next-generation sequencing can also be used in step 4.</p>
</section>
</section>
<section id="step-4-selecting-an-appropriate-igg-subclass" class="level4" data-number="2.4.3.3">
<h4 data-number="2.4.3.3" class="anchored" data-anchor-id="step-4-selecting-an-appropriate-igg-subclass"><span class="header-section-number">2.4.3.3</span> Step #4: Selecting an Appropriate IgG Subclass</h4>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="images/wk2/subclass.jpg" class="img-fluid figure-img" width="804"></p>
<p></p><figcaption class="figure-caption">Potential Uses and Side Effects of Different IgG Antibody Subclasses</figcaption><p></p>
</figure>
</div>
</div>
</div>
<p>Recall that IgG3 antibodies are generally never used in therapeutic antibody production due to its unfavorable diamond configuration.</p>
<p>However, both IgG1 and IgG2 / IgG4 antibodies can be used with the following side effects for:</p>
<ol type="1">
<li><p><strong>Blocking Activity</strong></p>
<p>IgG2 / IgG4 antibodies can be used to accomplish this without destroying the cell.</p>
<p>IgG1 antibodies can be used too, but they cause cell death.</p></li>
<li><p><strong>Cell Activation</strong></p>
<p>IgG2 / (engineered) IgG4 antibodies can be used to do this without killing the cell.</p>
<p>IgG1 antibodies can be used for this purpose too, albeit they kill the cell.</p></li>
<li><p><strong>Recruiting NK Cells</strong></p>
<p>IgG1 antibodies can be used for this.</p>
<p>Engineered IgG1 antibodies can lead to enhanced ADCCs.</p></li>
<li><p><strong>Recruiting Monocytes</strong></p>
<p>IgG1 antibodies are used for this.</p>
<p>Engineered IgG1 antibodies can lead to enhanced opsonisation<a href="#fn6" class="footnote-ref" id="fnref6" role="doc-noteref"><sup>6</sup></a>.</p></li>
<li><p><strong>Recruiting Complements</strong></p>
<p>Normal CDCs can help recruit IgG1 antibodies.</p>
<p>Likewise, enhancing CDCs can help recruit enhanced IgG1 antibodies.</p></li>
</ol>
</section>
</section>
<section id="step-5-humanizing-antibodies" class="level3" data-number="2.4.4">
<h3 data-number="2.4.4" class="anchored" data-anchor-id="step-5-humanizing-antibodies"><span class="header-section-number">2.4.4</span> Step #5: Humanizing Antibodies</h3>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="images/wk2/immuno.jpg" class="img-fluid figure-img" width="767"></p>
<p></p><figcaption class="figure-caption">Immunogenicity Risk of Antibody by Humanization Status</figcaption><p></p>
</figure>
</div>
</div>
</div>
<p>Humanizing antibodies decreases the risk of <strong>immunogenicity</strong>: the event that the body’s immune system attacks a non-self molecule.</p>
<p><strong>Chimeric antibodies</strong> are antibodies whose VH and VL regions from mice antibodies have been grafted onto a human antibody’s Fab fragment.</p>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="images/wk2/human.jpg" class="img-fluid figure-img" width="411"></p>
<p></p><figcaption class="figure-caption">Some Examples of Therapeutic Antibodies</figcaption><p></p>
</figure>
</div>
</div>
</div>
<p>In a <strong>humanized antibody</strong>, parts of the Fab’s CDR have been grafted on from mouse antibodies.</p>
<p>Some examples of FDA-approved antibodies are shown in the above table. Depending on the suffix of the antibody’s name, one can guess the origin of the antibody - most notably:</p>
<ol type="1">
<li>“-lumab” refers to a human antibody.</li>
<li>“-umab” refers to a mouse antibody.</li>
<li>“-ximab” refers to a chimeric antibody.</li>
</ol>
</section>
<section id="step-6-validating-molecules" class="level3" data-number="2.4.5">
<h3 data-number="2.4.5" class="anchored" data-anchor-id="step-6-validating-molecules"><span class="header-section-number">2.4.5</span> Step #6: Validating Molecules</h3>
<p>See the <a href="">following chapter</a> for more information!</p>
</section>
</section>
<section id="phages-and-library-displays" class="level2" data-number="2.5">
<h2 data-number="2.5" class="anchored" data-anchor-id="phages-and-library-displays"><span class="header-section-number">2.5</span> Phages and Library Displays</h2>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="images/wk2/bonel.jpg" class="img-fluid figure-img" width="280"></p>
<p></p><figcaption class="figure-caption">Some Nobel Prize Winners for the Development of Phage Libraries</figcaption><p></p>
</figure>
</div>
</div>
</div>
<p>A possible alternative to using animals to generate antibodies include using phage libraries (as outlined in <a href="#steps">section 2.4</a>).</p>
<p>The individuals behind the development of phage libraries have been awarded Nobel prizes (see above image).</p>
<section id="life-cycle-of-a-phage" class="level3" data-number="2.5.1">
<h3 data-number="2.5.1" class="anchored" data-anchor-id="life-cycle-of-a-phage"><span class="header-section-number">2.5.1</span> Life Cycle of a Phage</h3>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="images/wk2/life.jpg" class="img-fluid figure-img" width="298"></p>
<p></p><figcaption class="figure-caption">Life Cycle of a Bacteriophage</figcaption><p></p>
</figure>
</div>
</div>
</div>
<p>It is believed that M13 phage coat proteins are formed in the periplasm before they are packed into the phage in question.</p>
<p>Note that other phages (e.g., bacteriophage T7) can also be packed into the cytoplasm.</p>
</section>
<section id="phage-display-formats" class="level3" data-number="2.5.2">
<h3 data-number="2.5.2" class="anchored" data-anchor-id="phage-display-formats"><span class="header-section-number">2.5.2</span> Phage Display Formats</h3>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="images/wk2/disp.jpg" class="img-fluid figure-img" width="254"></p>
<p></p><figcaption class="figure-caption">Possible cDNA Outcomes from Recombination</figcaption><p></p>
</figure>
</div>
</div>
</div>
</section>
<section id="library-creation-from-cdna" class="level3" data-number="2.5.3">
<h3 data-number="2.5.3" class="anchored" data-anchor-id="library-creation-from-cdna"><span class="header-section-number">2.5.3</span> Library Creation from cDNA</h3>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="images/wk2/naiveclone.jpg" class="img-fluid figure-img" width="254"></p>
<p></p><figcaption class="figure-caption">Creating a Gene Library from Bacteriophages’ cDNA</figcaption><p></p>
</figure>
</div>
</div>
</div>
</section>
<section id="kunkel-mutagenesis" class="level3" data-number="2.5.4">
<h3 data-number="2.5.4" class="anchored" data-anchor-id="kunkel-mutagenesis"><span class="header-section-number">2.5.4</span> Kunkel Mutagenesis</h3>
<p>This was also prof. Asial’s focus during his PhD.</p>
<div class="cell" data-layout-align="center">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="images/wk2/kunkel.jpg" class="img-fluid figure-img" width="206"></p>
<p></p><figcaption class="figure-caption">Kunkel Mutagenesis Outlined</figcaption><p></p>
</figure>
</div>
</div>
</div>


</section>
</section>
<section id="footnotes" class="footnotes footnotes-end-of-document" role="doc-endnotes">
<hr>
<ol>
<li id="fn1"><p>This stands for <a href="https://en.wikipedia.org/wiki/Antibody-dependent_cellular_cytotoxicity">Antibody-dependent cellular cytotoxicity</a><a href="#fnref1" class="footnote-back" role="doc-backlink">↩︎</a></p></li>
<li id="fn2"><p>This stands for <a href="https://iqbiosciences.com/bioservices/in-vitro_bioservices/antibody-dependent-cellular-phagocytosis-adcp-assay/">Antibody-Dependent Cellular Phagocytosis</a><a href="#fnref2" class="footnote-back" role="doc-backlink">↩︎</a></p></li>
<li id="fn3"><p>This is called <strong>pinocytosis</strong><a href="#fnref3" class="footnote-back" role="doc-backlink">↩︎</a></p></li>
<li id="fn4"><p>While this can be used in practice, the resulting serum will be very crude and may not be as effective or safe as using a solution of monoclonal antibodies.<a href="#fnref4" class="footnote-back" role="doc-backlink">↩︎</a></p></li>
<li id="fn5"><p>This is because many different kinds of antibodies can be produced from the hybridoma cells.<a href="#fnref5" class="footnote-back" role="doc-backlink">↩︎</a></p></li>
<li id="fn6"><p>This is a process whereby a pathogen is surrounded by antibodies.<a href="#fnref6" class="footnote-back" role="doc-backlink">↩︎</a></p></li>
</ol>
</section>

</main> <!-- /main -->
<script id="quarto-html-after-body" type="application/javascript">
window.document.addEventListener("DOMContentLoaded", function (event) {
  const toggleBodyColorMode = (bsSheetEl) => {
    const mode = bsSheetEl.getAttribute("data-mode");
    const bodyEl = window.document.querySelector("body");
    if (mode === "dark") {
      bodyEl.classList.add("quarto-dark");
      bodyEl.classList.remove("quarto-light");
    } else {
      bodyEl.classList.add("quarto-light");
      bodyEl.classList.remove("quarto-dark");
    }
  }
  const toggleBodyColorPrimary = () => {
    const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
    if (bsSheetEl) {
      toggleBodyColorMode(bsSheetEl);
    }
  }
  toggleBodyColorPrimary();  
  const disableStylesheet = (stylesheets) => {
    for (let i=0; i < stylesheets.length; i++) {
      const stylesheet = stylesheets[i];
      stylesheet.rel = 'prefetch';
    }
  }
  const enableStylesheet = (stylesheets) => {
    for (let i=0; i < stylesheets.length; i++) {
      const stylesheet = stylesheets[i];
      stylesheet.rel = 'stylesheet';
    }
  }
  const manageTransitions = (selector, allowTransitions) => {
    const els = window.document.querySelectorAll(selector);
    for (let i=0; i < els.length; i++) {
      const el = els[i];
      if (allowTransitions) {
        el.classList.remove('notransition');
      } else {
        el.classList.add('notransition');
      }
    }
  }
  const toggleColorMode = (alternate) => {
    // Switch the stylesheets
    const alternateStylesheets = window.document.querySelectorAll('link.quarto-color-scheme.quarto-color-alternate');
    manageTransitions('#quarto-margin-sidebar .nav-link', false);
    if (alternate) {
      enableStylesheet(alternateStylesheets);
      for (const sheetNode of alternateStylesheets) {
        if (sheetNode.id === "quarto-bootstrap") {
          toggleBodyColorMode(sheetNode);
        }
      }
    } else {
      disableStylesheet(alternateStylesheets);
      toggleBodyColorPrimary();
    }
    manageTransitions('#quarto-margin-sidebar .nav-link', true);
    // Switch the toggles
    const toggles = window.document.querySelectorAll('.quarto-color-scheme-toggle');
    for (let i=0; i < toggles.length; i++) {
      const toggle = toggles[i];
      if (toggle) {
        if (alternate) {
          toggle.classList.add("alternate");     
        } else {
          toggle.classList.remove("alternate");
        }
      }
    }
    // Hack to workaround the fact that safari doesn't
    // properly recolor the scrollbar when toggling (#1455)
    if (navigator.userAgent.indexOf('Safari') > 0 && navigator.userAgent.indexOf('Chrome') == -1) {
      manageTransitions("body", false);
      window.scrollTo(0, 1);
      setTimeout(() => {
        window.scrollTo(0, 0);
        manageTransitions("body", true);
      }, 40);  
    }
  }
  const isFileUrl = () => { 
    return window.location.protocol === 'file:';
  }
  const hasAlternateSentinel = () => {  
    let styleSentinel = getColorSchemeSentinel();
    if (styleSentinel !== null) {
      return styleSentinel === "alternate";
    } else {
      return false;
    }
  }
  const setStyleSentinel = (alternate) => {
    const value = alternate ? "alternate" : "default";
    if (!isFileUrl()) {
      window.localStorage.setItem("quarto-color-scheme", value);
    } else {
      localAlternateSentinel = value;
    }
  }
  const getColorSchemeSentinel = () => {
    if (!isFileUrl()) {
      const storageValue = window.localStorage.getItem("quarto-color-scheme");
      return storageValue != null ? storageValue : localAlternateSentinel;
    } else {
      return localAlternateSentinel;
    }
  }
  let localAlternateSentinel = 'default';
  // Dark / light mode switch
  window.quartoToggleColorScheme = () => {
    // Read the current dark / light value 
    let toAlternate = !hasAlternateSentinel();
    toggleColorMode(toAlternate);
    setStyleSentinel(toAlternate);
  };
  // Ensure there is a toggle, if there isn't float one in the top right
  if (window.document.querySelector('.quarto-color-scheme-toggle') === null) {
    const a = window.document.createElement('a');
    a.classList.add('top-right');
    a.classList.add('quarto-color-scheme-toggle');
    a.href = "";
    a.onclick = function() { try { window.quartoToggleColorScheme(); } catch {} return false; };
    const i = window.document.createElement("i");
    i.classList.add('bi');
    a.appendChild(i);
    window.document.body.appendChild(a);
  }
  // Switch to dark mode if need be
  if (hasAlternateSentinel()) {
    toggleColorMode(true);
  } 
  const icon = "";
  const anchorJS = new window.AnchorJS();
  anchorJS.options = {
    placement: 'right',
    icon: icon
  };
  anchorJS.add('.anchored');
  const clipboard = new window.ClipboardJS('.code-copy-button', {
    target: function(trigger) {
      return trigger.previousElementSibling;
    }
  });
  clipboard.on('success', function(e) {
    // button target
    const button = e.trigger;
    // don't keep focus
    button.blur();
    // flash "checked"
    button.classList.add('code-copy-button-checked');
    var currentTitle = button.getAttribute("title");
    button.setAttribute("title", "Copied!");
    setTimeout(function() {
      button.setAttribute("title", currentTitle);
      button.classList.remove('code-copy-button-checked');
    }, 1000);
    // clear code selection
    e.clearSelection();
  });
  function tippyHover(el, contentFn) {
    const config = {
      allowHTML: true,
      content: contentFn,
      maxWidth: 500,
      delay: 100,
      arrow: false,
      appendTo: function(el) {
          return el.parentElement;
      },
      interactive: true,
      interactiveBorder: 10,
      theme: 'quarto',
      placement: 'bottom-start'
    };
    window.tippy(el, config); 
  }
  const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
  for (var i=0; i<noterefs.length; i++) {
    const ref = noterefs[i];
    tippyHover(ref, function() {
      // use id or data attribute instead here
      let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
      try { href = new URL(href).hash; } catch {}
      const id = href.replace(/^#\/?/, "");
      const note = window.document.getElementById(id);
      return note.innerHTML;
    });
  }
  var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
  for (var i=0; i<bibliorefs.length; i++) {
    const ref = bibliorefs[i];
    const cites = ref.parentNode.getAttribute('data-cites').split(' ');
    tippyHover(ref, function() {
      var popup = window.document.createElement('div');
      cites.forEach(function(cite) {
        var citeDiv = window.document.createElement('div');
        citeDiv.classList.add('hanging-indent');
        citeDiv.classList.add('csl-entry');
        var biblioDiv = window.document.getElementById('ref-' + cite);
        if (biblioDiv) {
          citeDiv.innerHTML = biblioDiv.innerHTML;
        }
        popup.appendChild(citeDiv);
      });
      return popup.innerHTML;
    });
  }
});
</script>
<nav class="page-navigation">
  <div class="nav-page nav-page-previous">
      <a href="./intro.html" class="pagination-link">
        <i class="bi bi-arrow-left-short"></i> <span class="nav-page-text"><span class="chapter-number">1</span>&nbsp; <span class="chapter-title">Introduction to Antibodies</span></span>
      </a>          
  </div>
  <div class="nav-page nav-page-next">
      <a href="./wk3.html" class="pagination-link">
        <span class="nav-page-text"><span class="chapter-number">3</span>&nbsp; <span class="chapter-title">Pre-clinical Validation of Antibodies</span></span> <i class="bi bi-arrow-right-short"></i>
      </a>
  </div>
</nav>
</div> <!-- /content -->



</body></html>